Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ray, Sandipan ^a   Renu, Durairaj ^b   Srivastava, Rajneesh ^a   Gollapalli, Kishore ^a   Taur, Santosh ^c   Jhaveri, Tulip ^c   Dhali, Snigdha ^d   Chennareddy, Srinivasarao ^e   Potla, Ankit ^b   Dikshit, Jyoti Bajpai ^b   Srikanth, Rapole ^d   Gogtay, Nithya ^c   Thatte, Urmila ^c   Patankar, Swati ^a   Srivastava, Sanjeeva ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b Strand Life Sciences Pvt Ltd ^*  (India)

^c KEM HOSPITAL   (India)

^d NATIONAL CENTRE FOR CELL SCIENCE   (India)

^e Wipro GE Healthcare   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; HAPTOGLOBIN; HEMOPEXIN; RETINOL BINDING PROTEIN; SURROGATE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FEVER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; LEPTOSPIROSIS; MALARIA FALCIPARUM; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MIDDLE AGED; MODELS, STATISTICAL; PHENOTYPE; PROTEIN INTERACTION MAPS; PROTEOMICS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84865019674     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041751     Document Type: Article

References (47)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, ((2005)) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:: 214--217.
2. WHO (2008) WHO World Malaria Report (WHO, Geneva) Available at http://www.who.int/malaria/wmr 2008/malaria2008.pdf. Accessed April 05, 2012.
3. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, et al. ((2007)) Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77 (6 Suppl). pp. 79--87.
4. Olszewski KL, Morrisey JM, Wilinski D, Burns JM, Vaidya AB, et al. ((2009)) Host-parasite interactions revealed by Plasmodium falciparum metabolomics. Cell Host Microbe 5:: 191--199.
5. Mishra SK, Newton CR, ((2009)) Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 5:: 189--198.
6. Francischetti IM, ((2008)) Does activation of the blood coagulation cascade have a role in malaria pathogenesis? Trends Parasitol 24:: 258--263.
7. Acharya P, Pallavi R, Chandran S, Chakravarti H, Middha S, et al. ((2009)) A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin appl 3:: 1314--1325.
8. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, et al. ((2010)) A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 107:: 6958--6963.
9. Fontaine A, Bourdon S, Belghazi M, Pophillat M, Fourquet P, et al. ((2012)) Plasmodium falciparum infection-induced changes in erythrocyte membrane proteins. Parasitol Res 110:: 545--556.
10. Ray S, Reddy PJ, Jain R, Gollapalli K, Moiyadi A, et al. ((2011)) Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 11:: 2139--2161.
11. Albuquerque LM, Trugilho MR, Chapeaurouge A, Jurgilas PB, Bozza PT, et al. ((2009)) Two dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res 8:: 5431--5441.
12. Chen JH, Chang YW, Yao CW, Chiueh TS, Huang SC, et al. ((2004)) Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci USA 101:: 17039--17044.
13. Rukmangadachar LA, Kataria J, Hariprasad G, Samantaray JC, Srinivasan A, ((2011)) Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin Proteomics 8:: 4.
14. Srivastava R, Ray S, Vaibhav V, Gollapalli K, Jhaveri T,et al. (2012) Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics. (In press:10.1016/j.jprot.2012.04.007).
15. Ray S, Kamath KS, Srivastava R, Raghu D, Gollapalli K, et al. ((2012)) Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response. J Proteomics 75:: 3063--3080.
16. Bahk YY, Na BK, Cho SH, Kim JY, Lim KJ, et al. ((2010)) Proteomic analysis of Haptoglobin and Amyloid A protein levels in patients with vivax malaria. Korean J Parasitol 48:: 203--211.
17. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, et al. ((2007)) Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malaria J 6:: 147.
18. Kassa FA, Shio MT, Bellemare MJ, Faye B, Ndao M, et al. ((2011)) New inflammation-related biomarkers during malaria infection. PLoS One 6:: e26495 doi:10.1371/journal.pone.0026495.
19. Taylor-Robinson AW, ((2000)) Increased production of acute-phase proteins corresponds to the peak parasitaemia of primary malaria infection. Parasitol Int 48:: 297--301.
20. Wenisch C, Spitzauer S, Florris-Linau K, Rumpold H, Vannaphan S, et al. ((1997)) Complement activation in severe Plasmodium falciparum malaria. Clin Immunol Immunopathol. 85:: 166--171.
21. Rougemont A, Bouvier M, Perrin L, Yerly S, Brenner E, et al. ((1988)) Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of two studies in a hyperendemic region in West Africa. Lancet 2:: 709--712.
22. Pied S, Tabone MD, Chatellier G, Marussig M, Jardel C, et al. ((1995)) Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins. Parasite 2:: 263--268.
23. Steel DM, Whitehead AS, ((1994)) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:: 81--88.
24. Kappelle PJ, Bijzet J, Hazenberg BP, Dullaart RP, ((2011)) Lower serum paraoxonase-1 activity is related to higher serum amyloid A levels in metabolic syndrome. Arch Med Res 42:: 219--225.
25. Pabon A, Carmona J, Burgos LC, Blair S, ((2003)) Oxidative stress in patients with non-complicated malaria. Clin Biochem 36:: 71--78.
26. Delanghe JR, Langlois MR, ((2001)) Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 312:: 13--23.
27. Yerly S, Bouvier M, Rougemont A, Srivastava I, Perrin LH, ((1990)) Development of a haptoglobin ELISA. Its use as an indicator for malaria. Acta Trop 47:: 237--244.
28. Harrison T, Samuel BU, Akompong T, Hamm H, Mohandas N, et al. ((2003)) Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301:: 1734--1736.
29. Wozniak MA, Faragher EB, Todd JA, Koram KA, Riley EM, et al. ((2003)) Does apolipoprotein E polymorphism influence susceptibility to malaria? J Med Genet 40:: 348--351.
30. Verhoeckx KC, Gaspari M, Bijlsma S, van der Greef J, Witkamp RF, et al. ((2005)) In search of secreted protein biomarkers for the anti-inflammatory effect of ß2-adrenergic receptor agonists: application of DIGE technology in combination with multivariate and univariate data analysis tools. J Proteome Res 4:: 2015--2023.
31. Pérez-Enciso M, Tenenhaus M, ((2003)) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet 112:: 581--592.
32. Omenn GS, ((2004)) Advancement of biomarker discovery and validation through the HUPO plasma proteome project. Dis Markers 20:: 131--134.
33. Payne D, ((1988)) Use and limitations of light microscopy for diagnosing malaria at the primary health care level. Bull World Health Organ 66:: 621--626.
34. Mockenhaupt FP, Rong B, Till H, Eggelte TA, Beck S, et al. ((2000)) Submicroscopic Plasmodium falciparum infections in pregnancy in Ghana. Trop Med Int Health 5:: 167--173.
35. WHO (2008) World Health Organization. List of known commercially available antigen-detecting malaria RDTs. Available at: http://www.wpro.who.int/sites/rdt. Accessed April 05, 2012.
36. Bell D, Peeling RW, ((2006)) WHO-Regional Office for the Western Pacific/TDR. Evaluation of rapid diagnostic tests: malaria. Nat Rev Microbiol 4 (9 Suppl). pp. S34--38.
37. Chen YY, Lin SY, Yeh YY, Hsiao HH, Wu CY, et al. ((2005)) A modified protein precipitation procedure for efficient removal of albumin from serum. Electrophoresis 26:: 2117--2127.
38. Benjamini Y, Hochberg Y, ((2000)) On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat 25:: 60--83.
39. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M, ((2006)) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1:: 2856--2860.
40. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P,et al. (2012) Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics. (In press: DOI 10.1002/pmic.201200002).
41. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, et al. ((2006)) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34:: W645--50.
42. Huang da W, Sherman BT, Lempicki RA, ((2009)) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:: 44--57.
43. Huang da W, Sherman BT, Lempicki RA, ((2009)) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:: 1--13.
44. Boulesteix AL, Strimmer K, ((2007)) Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief Bioinform 8:: 32--44.
45. Barker M, Rayens W, ((2003)) Partial least squares for discrimination. J Chemom 17:: 166--73.
46. Wold S, Esbensen K, Geladi P, ((1987)) Principal component analysis. Chem Intell Lab System 2:: 37--52.
47. Burges CJC, ((1998)) A tutorial on support vector machines for pattern recognition. Data Min Knowl Discov 2:: 121--167.